2021 Revenues ($USD) : $139,670,000
2021 R&D spend : $18,399,000
2021 Number of Employees : 456
Fiscal Year End : 12/31/2020
Key People : Bill Hoffman, CEO; Drew Hykes, COO; Mitch Hill, CFO; Tom Tu, chief medical officer; Paul Koehn, VP, operations; Tara Dunn, VP, clinical affairs and market development; John Borrell, VP, sales; Brian Strauss, VP, engineering; Eric Khairy, VP, marketing; Vitas Sipelis, VP, international; Eric Louw, VP, manufacturing; Janet Byk, VP, financing and accounting; Angela Ahmad, general counsel; Kevin Strange, VP, strategy and business development.

About the company: Inari Medical raised roughly $179.2 million from its IPO in May 2020. The company has developed two minimally-invasive, catheter-based mechanical thrombectomy devices to remove large clots from large vessels and eliminate the need for thrombolytic drugs. Both the company’s FlowTriever and ClotTriever are FDA-cleared for the removal of emboli and thrombi from the peripheral vasculature. The FlowTriever also has an FDA indication for the treatment of pulmonary embolism. –CN